A prospective trial of tacrolimus (FK 506) in clinical heart transplantation: Intermediate-term results
Open Access
- 1 April 1996
- journal article
- clinical trial
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 111 (4) , 764-772
- https://doi.org/10.1016/s0022-5223(96)70336-7
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver TransplantationNew England Journal of Medicine, 1994
- Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejectionThe Lancet, 1994
- A PROSPECTIVE RANDOMIZED TRIAL OF FK506 VERSUS CYCLOSPORINE AFTER HUMAN PULMONARY TRANSPLANTATION1Transplantation, 1994
- FK506 “RESCUE” FOR RESISTANT REJECTION OF RENAL ALLOGRAFTS UNDER PRIMARY CYCLOSPORINE IMMUNOSUPPRESSION1Transplantation, 1994
- Increased Incidence of Lymphoproliferative Disorder after Immunosuppression with the Monoclonal Antibody OKT3 in Cardiac-Transplant RecipientsNew England Journal of Medicine, 1990
- OPTIMAL PERIOPERATIVE IMMUNOSUPPRESSION IN CARDIAC TRANSPLANTATION USING RABBIT ANTITHYMOCYTE GLOBULINTransplantation, 1990
- FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATIONThe Lancet, 1989
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987
- Side effects of cyclosporin A treatment in patients with rheumatoid arthritisKidney International, 1986
- The problem of attributing deaths of nonadherers: The VA coronary bypass experienceControlled Clinical Trials, 1982